Verrica Pharmaceuticals Inc. (VRCA) Fundamentals

Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its lead product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a highly contagious and primarily pediatric viral skin disease, and common warts.
SHARE INFORMATION
Market Cap$ 108,899,240
Shares Outstanding41,094,053
Float26,360,888
Percent Float64.15%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 12,000,000
Latest Fiscal EPS$ -1.29
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions149
Institutional Holdings Date2022-10-31
Institutional Bought Previous 3 Months2,589,937
Institutional Holdings Percent41.8%
Institutional Sold Previous 3 Months2,785,801
Insider Holdings Date2022-10-31
Insider Bought Previous 3 Months-
Insider Holdings Percent41.4
Insider Sold Previous 3 Months-
Insider Shares Owned17,012,001
TRADING INFO
52 Week High$ 11.08
52 Week Low$ 1.77
52 Week High Change$ -74.86
21 Day Moving Average$ 2.419
21 Day Extended Moving Average$ 2.5079
50 Day Moving Average$ 2.624
50 Day Extended Moving Average$ 2.6888
200 Day Moving Average$ 4.5218
200 Day Extended Moving Average$ 4.5382
10 Day Average Volume67,051
20 Day Average Volume94,133
30 Day Average Volume80,680
50 Day Average Volume72,849
Alpha-0.024678
Beta1.9342
Standard Deviation0.240644
R20.201432
7 Day Price Change$ -0.15
7 Day Percent Change-5.36%
21 Day Price Change$ 0.43
21 Day Percent Change19.37%
30 Day Price Change$ 0.23
30 Day Percent Change9.5%
Month to Date Price Change$ 0.16
Month to Date Percent Change6.43%
Quarter to Date Price Change$ -0.27
Quarter to Date Percent Change-9.25%
180 Day Price Change$ 0.65
180 Day Percent Change32.5%
200 Day Price Change$ -3.01
200 Day Percent Change-53.18%
Year to Date Price Change$ -6.51
Year to Date Percent Change-71.07%

Verrica Pharmaceuticals Inc. (VRCA) Key Ratios

PROFITABILITY
EBIT Margin-277.0%
EBITDA Margin-269.2%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 8,964,000
Revenue Per Share$ 0.2181
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book2.40
Total Debt To Equity0.00
Int Coverage-7.60
Current Ratio14.10
Leverage Ratio2.20
Quick Ratio13.00
Long Term Debt To Capital0.03
VALUATION MEASURES
PE Ratio-2.50
Enterprise Value$ 68,163,656
Price to Sales12.1485
Price to Free Cash-4.60
PE High Last 5 Years0.00
Price To Book2.40
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book2.40
MANAGEMENT EFFECTIVENESS
Receivables Turnover43.40
Invoice Turnover0.00
Assets Turnover0.20
Return Assets-45.19
Return on Equity-70.79
Return on Capital-38.43

Verrica Pharmaceuticals Inc. (VRCA) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorKPMG LLP
CEOTed White
Emplyoees38
Last AuditUE
CIK0001660334
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address44 West Gay Street
Suite 400
West Chester, PA 19380
Websitehttps://www.verrica.com
Facsimile-
Telephone+1 484 453-3300
Emailinfo@verrica.com


Your Recent History
NASDAQ
VRCA
Verrica Pa..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.